Epoprostenol and thyroid disease

Endocr Pract. 2010 Jan-Feb;16(1):133; author reply 133-4. doi: 10.4158/EP.16.1.130.
No abstract available

Publication types

  • Kommentar
  • Letter

MeSH terms

  • Epoprostenol / adverse effects
  • Epoprostenol / therapeutic use*
  • Humans
  • Thyroid Diseases / drug therapy*

Substances

  • Epoprostenol